{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:53:30Z","timestamp":1786650810807,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/2229-5178.131071","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T04:34:28Z","timestamp":1398054868000},"page":"117","source":"Crossref","is-referenced-by-count":5,"title":["Role of the ACTH test and estimation of a safe dose for high potency steroids in vitiligo: A prospective randomized study"],"prefix":"10.4103","volume":"5","author":[{"given":"Alberto","family":"de la Fuente-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"G\u00f3mez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mancillas-Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliverio","family":"Welsh-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Zacar\u00edasVillarreal","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9Gerardo","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lavalle-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.131071-1","first-page":"160","volume-title":"Clinical practice.Vitiligo","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.131071-2","first-page":"236","volume-title":"High-potency steroid use in children with vitiligo: A retrospective study","author":"Kwinter","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.131071-3","first-page":"47","volume-title":"Prevalence of vitiligo.Epidemiological survey on the Isle of Bornholm, Denmark","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.131071-4","first-page":"18","volume-title":"Epidemiology of vitiligo in the French West Indies (Isle of Martinique)","author":"Boisseau-Garsaud","year":"2000","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2229-5178.131071-5","first-page":"671","volume-title":"Segmental vitiligo: Clinical findings in 208 patients","author":"Hann","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.131071-6","first-page":"1514","volume-title":"The development of guidelines for the treatment of vitiligo.Clinical Epidemiology Unit of the Istituto Dermopatico dell\u2032Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology","author":"Njoo","year":"1999","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2229-5178.131071-7","first-page":"907","volume-title":"Non PUVA nonsurgical therapies for vitiligo","author":"Mandel","year":"1997","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.131071-8","first-page":"1051","volume-title":"Guideline for the diagnosis and management of vitiligo","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.131071-9","first-page":"318","volume-title":"Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations","author":"Gilbertson","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.131071-10","first-page":"767","volume-title":"Acute adrenal insufficiency","author":"Bouillon","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/2229-5178.131071-11","first-page":"141","volume-title":"Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications","author":"Levin","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/2229-5178.131071-12","first-page":"246","volume-title":"Topical clobetasol-17-propionate: Review of its clinical efficacy and safety","author":"Olsen","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.131071-13","first-page":"1","volume-title":"Adverse effects of topical glucocorticosteroids","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.131071-14","first-page":"275","volume-title":"A high-sensitivity test in the assessment of adrenocortical insufficiency: 10 microg vs 250 microg cosyntropin dose assessment of adrenocortical insufficiency","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"1998","journal-title":"J Endocrinol"},{"key":"key-10.4103\/2229-5178.131071-15","first-page":"633","volume-title":"Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: Sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test","author":"Tordjman","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/2229-5178.131071-16","first-page":"4245","volume-title":"Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: A metaanalysis","author":"Kazlauskaite","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/2229-5178.131071-17","first-page":"1149","volume-title":"Sodium retention and edema from percutaneous absorption of fludrocortisone acetate","author":"Fitzpatrick","year":"1955","journal-title":"J Am Med Assoc"},{"key":"key-10.4103\/2229-5178.131071-18","first-page":"497","volume-title":"Use of glucocorticosteroids in psoriasis","author":"Cornell","year":"1980","journal-title":"Pharmacol Ther"},{"key":"key-10.4103\/2229-5178.131071-19","first-page":"428","volume-title":"The use of corticosteroids in dermatological practice","author":"Barnetson","year":"1992","journal-title":"Med J Aust"},{"key":"key-10.4103\/2229-5178.131071-20","first-page":"15","volume-title":"Side effects of topical corticosteroids and their prevention","author":"Takeda","year":"1988","journal-title":"Drugs"},{"key":"key-10.4103\/2229-5178.131071-21","first-page":"26","volume-title":"Adverse effects of topical corticosteroids","author":"Pi\u00e9rard","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"key-10.4103\/2229-5178.131071-22","first-page":"619","volume-title":"Effect on adrenal function of topically applied clobetasol propionate (Dermovate)","author":"Allenby","year":"1975","journal-title":"Br Med J"},{"key":"key-10.4103\/2229-5178.131071-23","first-page":"645","volume-title":"In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers","author":"Wester","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.131071-24","first-page":"884","volume-title":"Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids","author":"Sheu","year":"1997","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.131071-25","first-page":"456","volume-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis accounts for functional abnormalities","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.131071-26","first-page":"347","volume-title":"Corticosteroids induce proliferation but do not influence TNF- or IL-1 beta-induced ICAM-1 expression of human dermal microvascular endothelial cells in vitro","author":"Hettmannsperger","year":"1993","journal-title":"Arch Dermatol Res"},{"key":"key-10.4103\/2229-5178.131071-27","first-page":"655","volume-title":"Glucocorticoids and infection","author":"Aucott","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/2229-5178.131071-28","first-page":"71","volume-title":"A double-blind trial of 0 - 05% clobetasol propionate in the treatment of vitiligo","author":"Clayton","year":"1977","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.131071-29","first-page":"457","volume-title":"Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol-a double-blind trial","author":"Kandil","year":"1974","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.131071-30","first-page":"1061","volume-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs.either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:23:12Z","timestamp":1786648992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-5178.131071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["131071"],"URL":"https:\/\/doi.org\/10.4103\/2229-5178.131071","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}